FDA Warning Letter Calls Attention to Celltrion's 'Poor' Aseptic Practices

FDA warning letter to South Korean manufacturer Celltrion cites an extensive list of problems related to inadequate contamination controls and shows how companies launching biosimilars can be tripped up by GMP compliance problems.